{
      "brief_title": [
            "tarceva",
            "treat",
            "patient",
            "stage",
            "iii",
            "stage",
            "iv",
            "cell",
            "lung",
            "cancer"
      ],
      "brief_summary": [
            "purpose",
            "study",
            "determine",
            "improve",
            "overall",
            "survival",
            "patient",
            "incurable",
            "stage",
            "cell",
            "lung",
            "cancer",
            "compare",
            "standard",
            "care",
            "new",
            "type",
            "drug",
            "evaluation",
            "call",
            "epidermal",
            "growth",
            "factor",
            "receptor",
            "egfr",
            "investigational",
            "drug",
            "yet",
            "approve",
            "food",
            "drug",
            "administration",
            "fda"
      ],
      "condition": [
            "lung"
      ],
      "intervention_type": [
            "Drug"
      ],
      "intervention_name": [
            "Tarceva (erlotinib HCl, OSI-774 )"
      ],
      "criteria": [
            "clinical",
            "diagnosis",
            "stage",
            "iiib",
            "iv",
            "cell",
            "lung",
            "cancer",
            "must",
            "evidence",
            "disease",
            "clinical",
            "radiological",
            "fail",
            "1",
            "2",
            "prior",
            "chemotherapy",
            "regimen",
            "recover",
            "side",
            "effect",
            "chemotherapy",
            "least",
            "21",
            "day",
            "patient",
            "surgery",
            "surgery",
            "least",
            "2",
            "week",
            "ago",
            "patient",
            "whose",
            "cancer",
            "spread",
            "brain",
            "central",
            "nervous",
            "system",
            "eligible",
            "provide",
            "stable",
            "dose",
            "steroid",
            "least",
            "4",
            "week",
            "free",
            "symptom",
            "patient",
            "receive",
            "radiation",
            "therapy",
            "treatment",
            "least",
            "4",
            "week",
            "ago"
      ],
      "gender": "All",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "keyword": [
            "erlotinib"
      ],
      "mesh_term": [
            "neoplasm",
            "lung",
            "hydrochloride"
      ],
      "id": "NCT00036647"
}